Business Description
Belite Bio Inc
NAICS : 325412
SIC : 2834
ISIN : US07782B1044
Share Class Description:
BLTE: ADRDescription
Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively lead to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Equity-to-Asset | 0.97 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.03 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -70.4 | |||||
| 3-Year EPS without NRI Growth Rate | -70.8 | |||||
| 3-Year FCF Growth Rate | -82.5 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 19.63 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 48.99 | |||||
| 9-Day RSI | 40.76 | |||||
| 14-Day RSI | 39.68 | |||||
| 3-1 Month Momentum % | 12.61 | |||||
| 6-1 Month Momentum % | 30.94 | |||||
| 12-1 Month Momentum % | 36.61 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -6.6 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -35.41 | |||||
| ROA % | -33.87 | |||||
| ROIC % | -44.5 | |||||
| 3-Year ROIIC % | -446.51 | |||||
| ROC (Joel Greenblatt) % | -46.73 | |||||
| ROCE % | -36.59 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 15.47 | |||||
| Price-to-Tangible-Book | 15.48 | |||||
| EV-to-EBIT | -46.54 | |||||
| EV-to-Forward-EBIT | -27.31 | |||||
| EV-to-EBITDA | -46.54 | |||||
| EV-to-FCF | -55.13 | |||||
| Price-to-Net-Current-Asset-Value | 16.11 | |||||
| Earnings Yield (Greenblatt) % | -2.15 | |||||
| FCF Yield % | -1.72 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:BLTE
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Belite Bio Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -1.1 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 53.07 | ||
| 14-Day RSI | 39.68 | ||
| 14-Day ATR ($) | 3.437767 | ||
| 20-Day SMA ($) | 59.7585 | ||
| 12-1 Month Momentum % | 36.61 | ||
| 52-Week Range ($) | 31.005 - 86.53 | ||
| Shares Outstanding (Mil) | 30.88 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Belite Bio Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Belite Bio Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Belite Bio Inc Frequently Asked Questions
What is Belite Bio Inc(BLTE)'s stock price today?
The current price of BLTE is $56.21. The 52 week high of BLTE is $86.53 and 52 week low is $31.01.
When is next earnings date of Belite Bio Inc(BLTE)?
The next earnings date of Belite Bio Inc(BLTE) is 2025-03-12 Est..
Does Belite Bio Inc(BLTE) pay dividends? If so, how much?
Belite Bio Inc(BLTE) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers